Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Virneliz Fernández Vega"'
Autor:
Luis M. Ortiz Jordan, Virneliz Fernández Vega, Justin Shumate, Adam Peles, Jordan Zeiger, Louis Scampavia, Timothy P. Spicer
Publikováno v:
SLAS Discovery, Vol 29, Iss 3, Pp 100141- (2024)
High Throughput Screening (HTS) with 3D cell models is possible thanks to the recent progress and development in 3D cell culture technologies. Results from multiple studies have demonstrated different drug responses between 2D and 3D cell culture. It
Externí odkaz:
https://doaj.org/article/482d07966d634fcfad48ee4a6637718a
Autor:
Virneliz Fernández Vega, Dong Yang, Luis Ortiz Jordán, Fei Ye, Louis Conway, Li Yun Chen, Justin Shumate, Pierre Baillargeon, Louis Scampavia, Christopher Parker, Ben Shen, Timothy P. Spicer
Publikováno v:
SLAS Discovery, Vol 28, Iss 2, Pp 20-28 (2023)
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for ∼84% of all lung cancer cases. NSCLC remains one of the leading causes of cancer-associated death, with a 5-year survival rate less than 25%. This type of ca
Externí odkaz:
https://doaj.org/article/3e49c444351c49eaa92e3aaa15039015
Autor:
Timothy P, Spicer, Virneliz Fernández, Vega, Louis, Scampavia, Lynsey, Willetts, Michelle, Vessels
Publikováno v:
Bioprocess Int
Autor:
Pamela Y Ting, Robert Damoiseaux, Björn Titz, Kenneth A Bradley, Thomas G Graeber, Virneliz Fernández-Vega, Thomas D Bannister, Peter Chase, Reji Nair, Louis Scampavia, Peter Hodder, Timothy P Spicer, John Colicelli
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121833 (2015)
Constitutively active BCR-ABL kinase fusions are causative mutations in the pathogenesis of hematopoietic neoplasias including chronic myelogenous leukemia (CML). Although these fusions have been successfully targeted with kinase inhibitors, drug-res
Externí odkaz:
https://doaj.org/article/2fdb029e4895452f97d6cb019cbf0f41